Cargando…

Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease

BACKGROUND: Myxomatous mitral valve disease (MMVD) is the most common diagnosed cardiovascular disease in dogs. Atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) tests are used to diagnose congestive heart failure, but there are conflicting reports about their value in diagnosing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khaki, Zohreh, Nooshirvani, Parviz, Shirani, Darioush, Masoudifard, Majid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784259/ https://www.ncbi.nlm.nih.gov/pubmed/36564735 http://dx.doi.org/10.1186/s12917-022-03548-2

Ejemplares similares

N-terminal pro–B-type natriuretic peptide levels in normotensive and hypertensive dogs with myxomatous mitral valve disease stage B
por: Jang, In Sung, et al.
Publicado: (2023)

Is Atrial Natriuretic Peptide (ANP) and Natriuretic Peptide Receptor-A (NPR-A) Expression in Human Placenta and Decidua Normal?
por: Tan, Hongchuan, et al.
Publicado: (2019)

Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP)
por: Maries, Lorena, et al.
Publicado: (2013)

Ratio of preoperative atrial natriuretic peptide to brain natriuretic peptide predicts the outcome of the maze procedure in mitral valve disease
por: Sato, Masafumi, et al.
Publicado: (2013)

Comparison of N-terminal pro-atrial natriuretic peptide and three cardiac biomarkers for discriminatory ability of clinical stage in dogs with myxomatous mitral valve disease
por: OGAWA, Mizuki, et al.
Publicado: (2021)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)

Atrial natriuretic peptide (ANP) and oxytocin-expression in the adult rat and mouse cerebellum
por: Lipari, Alessio, et al.
Publicado: (2015)

Role of atrial natriuretic peptide (ANP) in the regulation of insulin secretion and vitality of pancreatic ß cells
por: Tauscher, Sabine, et al.
Publicado: (2015)

Pregnancy-specific Reference Intervals for BNP and NT-pro BNP—Changes in Natriuretic Peptides Related to Pregnancy
por: Dockree, Samuel, et al.
Publicado: (2021)

The chromogranin A-derived peptides catestatin and vasostatin in dogs with myxomatous mitral valve disease
por: Höglund, Katja, et al.
Publicado: (2020)

Heads and Tails of Natriuretic Peptides: Neuroprotective Role of Brain Natriuretic Peptide
por: Fernández‐Susavila, Héctor, et al.
Publicado: (2017)

A splice variant of the guanylyl cyclase-A receptor interferes with atrial natriuretic peptide (ANP) signaling
por: Hartmann, Michael, et al.
Publicado: (2009)

Periprocedural changes in natriuretic peptide levels and clinical outcome after transcatheter mitral valve repair
por: Tanaka, Tetsu, et al.
Publicado: (2021)

A Novel Bioassay for the Activity Determination of Therapeutic Human Brain Natriuretic Peptide (BNP)
por: Yu, Lei, et al.
Publicado: (2012)

Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A
por: Vink, Simone, et al.
Publicado: (2023)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

Brain Natriuretic Peptide (BNP) and N-Terminal-proBNP in Cardio-Renal Anemia Syndrome　― Difference in Prognostic Ability ―
por: Otaki, Yoichiro, et al.
Publicado: (2019)

Myxomatous degeneration of the mitral valve
por: Neto, Felippe Lazar, et al.
Publicado: (2018)

B-type natriuretic peptide (NT-proBNP) and thyroid function: study in elderly subjects
por: Mastroianni, S, et al.
Publicado: (2010)

Breed Differences in Natriuretic Peptides in Healthy Dogs
por: Sjöstrand, K., et al.
Publicado: (2014)

The virtually mature B‐type natriuretic peptide (BNP1‐32) is a precursor for the more effective BNP1‐30
por: Schwiebs, Anja, et al.
Publicado: (2020)

A novel natriuretic peptide
por: Höfeld, Hanna, et al.
Publicado: (2011)

Natriuretic peptides and fat metabolism
por: Collins, Sheila
Publicado: (2013)

Natriuretic peptides in cardiovascular diseases
por: Piechota, Mariusz, et al.
Publicado: (2008)

Natriuretic Peptides, Cardio-Oncology…
Publicado: (2023)

Pro-atrial natriuretic peptide (pro-ANP) level in patients with severe sepsis and septic shock: prognostic and diagnostic significance
por: Lipinska-Gediga, M., et al.
Publicado: (2012)

Plasmatic Dimethylarginines in Dogs With Myxomatous Mitral Valve Disease
por: Valente, Carlotta, et al.
Publicado: (2021)

Comparison of N-Terminal Pro B-Natriuretic Peptide and Echocardiographic Indices in Patients with Mitral Regurgitation
por: Hajsadeghi, Shokoufeh, et al.
Publicado: (2010)

Functional Role of Natriuretic Peptides in Risk Assessment and Prognosis of Patients with Mitral Regurgitation
por: Gallo, Giovanna, et al.
Publicado: (2020)

Depletion of proBNP(1-108) in Patients with Heart Failure Prevents Cross-Reactivity with Natriuretic Peptides
por: Roubille, François, et al.
Publicado: (2013)

B-Type Natriuretic Peptide (BNP) Revisited—Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?
por: Nishikimi, Toshio, et al.
Publicado: (2022)

Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP – A narrative review
por: Kerr, Brian, et al.
Publicado: (2022)

Calcineurin Regulates Homologous Desensitization of Natriuretic Peptide Receptor-A and Inhibits ANP-Induced Testosterone Production in MA-10 Cells
por: Henesy, Michelle B., et al.
Publicado: (2012)

The atrial natriuretic peptide (ANP) knockout mouse does not exhibit the phenotypic features of pre-eclampsia or demonstrate fetal growth restriction
por: Finn-Sell, Sarah L., et al.
Publicado: (2016)

Study of the Effect of Treatment With Atrial Natriuretic Peptide (ANP) and Cinaciguat in Chronic Hypoxic Neonatal Lambs on Residual Strain and Microstructure of the Arteries
por: Navarrete, Alvaro, et al.
Publicado: (2020)

Respiratory morbidity in preterm infants predicted by natriuretic peptide (MR-proANP) and endothelin-1 (CT-proET-1)
por: Gerull, Roland, et al.
Publicado: (2021)

Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms
por: Takashio, Seiji, et al.
Publicado: (2019)

Caveats in the interpretation of natriuretic peptide levels
por: Chao, Chia-Ter
Publicado: (2011)

Natriuretic Peptide Testing in Primary Care
por: Rehman, Shafiq U, et al.
Publicado: (2008)

Human genetics, natriuretic peptides and hypertension
por: Newton-Cheh, Christopher
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tfbd8ggtb3l2mm0i00l4obn8km